A family history of diabetes may be linked to chronic kidney disease progression, whereas family history of kidney disease ...

Yo-Yo Dieting May Significantly Increase Kidney Disease Risk in People With Type 1 Diabetes Feb. 4, 2025 — Body-weight cycling (also known as yo-yo dieting) has been shown to significantly ...

Johnson & Johnson's Invokana (canagliflozin) meanwhile also has an indication for diabetic kidney disease, but has been ... be the first obesity-targeted GLP-1 in pill form.

Though retrospective, the findings provide ‘compelling’ evidence that GLP-1 receptor agonists may help prevent development ...

Novo Nordisk has abandoned a drug it licensed from KBP Biosciences last year in a deal valued at up to $1.3 billion ... risk and kidney disease in people with diabetes and obesity.

The diabetes-related risk of stroke also may be higher in historically marginalized populations. Black, Hispanic, and American Indian populations have a higher prevalence of acquiring both diabetes ...

A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the ...

A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the ...

Researchers found that higher urinary levels of caffeine and specific metabolites, especially in men, were significantly ...

Orphan drug specialist Amicus Therapeutics is paying Dimerix $30 million cash for U.S. rights to the phase 3 prospect DMX-200 ...

Nationally representative survey data revealed that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) use for obesity ...